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ABSTRAK
Pengukuran ketumpatan mineral tulang oleh 'Dual-energy X-ray Absorptiometry' 
(DXA) adalah penting untuk mengenalpasti osteoporosis. Ralat ketepatan DXA 
adalah ukuran yang penting untuk menentukan perubahan sebenar dalam nilai 
ketumpatan mineral tulang. Kajian ini bertujuan untuk mengkaji pekali variasi 
jangka pendek mesin QDR Wi DXA Discovery Hologic. Ketumpatan mineral 
tulang pinggul dan tulang belakang untuk lima belas sukarelawan (purata umur: 
30.67 + 10.41 tahun) dan ketumpatan tulang keseluruhan badan untuk lima belas 
ekor tikus Sprague-Dawley betina (berusia tiga bulan) diimbas menggunakan mesin 
HDR Discover QDR Wi DXA. Setiap sukarelawan dan tikus menjalani imbasan 
sebanyak tiga kali untuk menilai kebolehulangan nilai ketumpatan tulang. Imbasan 
untuk subjek manusia dilakukan dalam  tempoh 1 hingga 12 minggu. Untuk 
sampel haiwan, imbasan diulang pada hari yang sama selepas posisi semula. Ralat 
kepersisan dinyatakan sebagai peratusan pekali variasi (%CV). %CV diperolehi 
untuk tulang belakang lumbar adalah 1.8% dan 1.2% untuk tulang pinggul. %CV 
untuk keseluruhan BMD tikus adalah 1.4%. %CV jangka pendek yang ditunjukkan 
untuk kedua-dua manusia dan haiwan dalam kajian ini adalah setanding. Ralat 
kepersisan DXA mesti dipantau untuk memastikan prestasi yang optimum.
Kata kunci: dual-energy-X-ray absorptiometry, in vivo, ketumpatan mineral tulang, 
ralat kepersisan
ABSTRACT
Bone mineral density (BMD) measurement by dual-energy X-ray absorptiometry 
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(DXA) is important in diagnosing osteoporosis. Precision error of DXA is a useful 
measure to determine a true change in BMD value. This study aimed to investigate 
the short-term coefficient of variance of Hologic Discovery QDR Wi DXA machine. 
The lumbar spine and hip BMD of fifteen healthy volunteers (mean age: 30.67 + 
10.41 years) and the whole body BMD of fifteen female Sprague-Dawley rats (aged 
three months old) were scanned using Hologic Discovery QDR Wi DXA machine. 
Each volunteer and rat underwent triplicate scans to assess the reproducibility of 
BMD values. The interval between the scans ranged within 1 to 12 weeks for 
human subjects. For animal samples, the scans were repeated on the same day 
after repositioning. The precision error was expressed as a percentage coefficient 
of variance (%CV). The %CV obtained for lumbar spine and hip BMD for human 
were 1.8% and 1.2%, respectively. The %CV for whole body BMD of rats was 
1.4%. The short-term CV demonstrated for both human and animal in the present 
study were comparable. The precision error of DXA must be monitored to ensure 
optimal performance of the device.
Keywords: bone mineral density, dual-energy-X-ray absorptiometry, in vivo, precision
Maghraoui et al. 2005). It may involve 
30 subjects, each with two repeated 
scans, or 15 subjects, each with three 
repeated scans (Kim & Yang 2014). The 
precision error is commonly expressed 
as the coefficient of variation (CV) 
which is the ratio of the standard 
deviation (SD) to the mean of the 
measurements (Boutsen et al. 2001). 
Previous reports indicated that a 
change in BMD greater than 2√2 %CV 
should be considered as a true change 
(Fuleihan et al. 1995). DXA also has 
been used to measure BMD in small 
animals (Lochmüller et al. 2001). The 
BMD of small animals, such as rats and 
mice, has been difficult to measure 
with the DXA technique because 
of their small bone size and relative 
lack of machine sensitivity. Thus, it is 
important to minimize the technical 
errors between measurements to 
enhance its accuracy. However, there 
INTRODUCTION
Assessment of bone mineral density 
(BMD) is an important step to 
determine bone loss in an individual. 
Dual-energy X-ray absorptiometry 
(DXA) is known to be the gold 
standard technique to assess BMD 
(World Health Organization 1994). 
The physicians need to identify a 
true change on BMD when a second 
scan is performed on a patient (El 
Maghraoui et al. 2005). Therefore, 
the measurement of precision of DXA 
is important in determining whether 
the change in BMD was random 
or significant due to interventions. 
The precision of a diagnostic test 
indicates the reproducibility of its 
measurements. Short-term precision 
of a DXA machine is established by 
repeated BMD measurements carried 
out over a short period of time (El 
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is a paucity of data on %CV values of 
DXA in small animals. 
 This paper aimed to demonstrate 
how the short term in-vivo precision 
of DXA in human and animal studies 
was calculated, using Hologic 
Discovery QDR Wi DXA machine as 
an example. Hologic Discovery QDR 
Wi DXA machine is one of the most 
widely used DXA model currently. The 
manufacturer provided a short-term 
%CV value of 1%. We hypothesize 
that we would obtain a slightly larger 
%CV value in the real world setting. 
MATERIALS AND METHODS
BMD was measured using Hologic 
Discovery QDR Wi DXA machine 
(MA, USA) with 13.5.3 analysis 
software. Calibration of the machine 
was performed before each scanning 
session using a Hologic calibration 
phantom. The same operator 
performed all the scanning and 
analysis. The scanning was repeated 
three times for each human subject 
and rat.
Human subjects
A total of 15 healthy nongravid 
volunteers aged 23-45 (mean 
age=30.67 + 10.41 years; men=6, 
women=9) without any metal implants 
on the site of assessment were recruited 
conveniently at a university in Kuala 
Lumpur, Malaysia. Informed consent 
was obtained from each volunteer 
prior to the scanning. BMD of their 
lumbar spine (L1-L4) and left hip was 
measured as per the standard protocol. 
For spine BMD scan, volunteers lied 
down in a supine position and a 
block provided by the manufacturer 
was used to elevate the legs (Figure 
1). For the left hip measurement, the 
left leg of the subject was rotated 
internally and the foot was strapped 
onto the positioning device to prevent 
movement while the subject remained 
in the supine position (Figure 2). Each 
volunteer was scanned three times on 
a different day within 1 to 12 weeks. 
Animal samples
Fifteen female Sprague-Dawley rats 
aged 3 months old weighing between 
200-250 g were procured from the 
Laboratory Animal Resource Unit, 
Figure 1: Position for spine BMD measurement by DXA
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Universiti Kebangsaan Malaysia 
Medical Centre (Kuala Lumpur, 
Malaysia). Whole body scan was 
performed onto the rats in a prone 
position when they were anaesthetized 
using a mixture of ketamine/xylazine. 
The scan began from the nose and 
extending to the end of the tail (Figure 
3). Rats were scanned three times by 
repositioning immediately after the 
first scan (4 minutes later).  
Ethical Consideration
The current study was part of the 
projects GUP-2017-012 and GUP-2017-
060. The protocols of the main studies 
have been reviewed and approved 
by the Ethics Committee of Universiti 
Kebangsaan Malaysia (approval code: 




Data analysis was computed using 
Microsoft Excel 2013 (Redmond, 
Washington). BMD measurement was 
done three times on each sample to 
achieve a degree of freedom (df) of 30 
as recommended by the International 
Society of Clinical Densitometry (ISCD). 
The df for the study is determined 
by the following formula: (number of 
measurements on each individual – 1) 
x (number of individuals in the study). 
The characteristics of human subjects 
and rats were reported as the mean 
and standard deviation. Precision was 
expressed as the percentage coefficient 
of variance (%CV) where:
 %CV = Standard deviation x 100
      Mean
Figure 2: Position for left hip BMD measurement by DXA
Figure 3: Image of the total body scan of the rats 
from the nose to the tail by DXA
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RESULTS
The mean height, weight and body 
mass index (BMI) of the volunteers 
were 161 + 5.19 cm, 58.40 + 7.74 kg 
and 22.3 + 2.8 kg/m2, respectively. 
Table 1 and Table 2 show the short-
term in vivo precision of measurements 
for the spine and left hip BMD of the 
volunteers, respectively. The mean 
%CV varied between 0.30 and 4.0 % 
for spinal BMD while for hip BMD, 
the mean %CV varied from 0.2 and 
2.5%. Table 3 shows the short-term 
in vivo precision of measurements for 
the whole body BMD of the rats. The 
mean %CV of whole body BMD in rats 
also varied from 0.20% and 2.44%.
DISCUSSION
This paper demonstrated the precision 
of BMD analysis for both spine and hip 
region of human subject and the whole 
body of rats using Hologic Discovery 
QDR Wi DXA machine. The short-
term %CV obtained for human in the 
present study was 1.8% for spinal BMD 
and 1.2% for total hip BMD. Several 
epidemiological studies using Hologic 
Discovery QDR Wi reported similar 
%CV values (Ho-Pham et al. 2011; 
Limpaphayom et al. 2001). Wapniarz 
et al. (1994) found a lower %CV for 
spinal BMD (1.02%) and femoral 
neck BMD (1.72%) among forty-eight 
patients (Wapniarz et al. 1994). The 
%CV values generated from the current 
study showed good reproducibility of 
Volunteer Reading 1 Reading 2 Reading 3 %CV (SD in g/cm2)
1 0.908 0.878 0.853 3.1(0.028)
2 0.9 0.872 0.86 2.3(0.021)
3 0.935 0.915 0.988 4.0(0.038)
4 0.724 0.731 0.737 0.9(0.007)
5 1.163 1.175 1.177 0.6(0.008)
6 0.874 0.898 0.891 1.4(0.012)
7 0.973 0.949 0.95 1.4(0.014)
8 1.041 1.034 1.031 0.5(0.005)
9 1.04 0.964 1.016 3.9 (0.039)
10 0.947 0.93 0.908 2.1(0.020)
11 0.829 0.857 0.812 2.7(0.023)
12 1.049 1.045 1.091 2.4(0.025)
13 0.806 0.805 0.801 0.3(0.003)
14 1.177 1.184 1.155 1.3(0.015)
15 1.067 1.066 1.057 0.5(0.006)
Range 0.3-4.0
 %CV 1.8
Abbreviation: CV: Coefficient of variance; SD: Standard deviation 
Table 1: In vivo precision for spine BMD of human
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BMD measurement especially for hip 
measurement. This might be due to 
the recruitment of younger subjects 
in our study, which made the hip 
rotation to be easier during scans. A 
similar finding has been observed in a 
previous study involving 47 Caucasian 
subjects (13 younger postmenopausal 
women; 17 elderly women; 17 men) 
whereby the measurement error for 
femur among younger subjects was 
smaller than that of the elderly subjects 
(Maggio et al. 1998). Generally, the 
%CV at the spine is usually 1-2% and 
2-3% at the proximal femur. These 
values vary depending on various 
factors, such as the type of machines 
used and experience of the technician 
(El Maghraoui & Roux 2008).
 Studies reporting in vivo bone 
densitometry measurement of the rats 
using DXA Hologic Discovery QDR Wi 
are limited. Therefore, comparison was 
made with studies using other models 
of DXA in the following discussion. The 
%CV observed in our present study for 
the whole body BMD of 15 female 
Sprague Dawley rats was 1.4%. This 
value was similar to the 1.4% reported 
by Karahan et al. (2002) using a DPX-L 
DXA model (Lunar Corp, Madison, 
Wisconsin) for the whole body BMD 
in 12 male Wistar rats (Karahan et al. 
2002). It was also comparable to the 
%CV of 1.5% reported in 10 Wistar 
rats (5 male and 5 female) using 
Hologic QDR 1000®, software version 
5.52 (Casez et al. 1994). In addition, 
Ammann et al. (1992) demonstrated 
that the %CV varies depending on the 
Volunteer Reading 1 Reading 2 Reading 3 %CV (SD in g/cm2)
1 0.851 0.848 0.852 0.2(0.002)
2 0.778 0.778 0.763 1.1(0.009)
3 0.803 0.797 0.806 0.6(0.005)
4 0.669 0.661 0.655 1.1(0.007)
5 1.063 1.091 1.04 2.4(0.026)
6 0.811 0.812 0.819 0.5(0.004)
7 0.92 0.897 0.881 2.2(0.020)
8 0.959 0.945 0.954 0.7(0.007)
9 0.926 0.928 0.942 0.9(0.009)
10 0.77 0.792 0.787 1.5(0.012)
11 0.728 0.726 0.712 1.2(0.009)
12 0.857 0.879 0.86 1.4(0.012)
13 0.709 0.692 0.708 1.4(0.010)
14 0.782 0.779 0.814 2.5(0.019)
15 0.831 0.825 0.815 1.0(0.008)
Range 0.2-2.5
 %CV 1.2
Abbreviation: CV: Coefficient of variance; SD: Standard deviation 
Table 2: In vivo precision for left hip BMD of human
76
Med & Health Jun 2020;15(1): 70-77 Subramaniam S. et al.
site of measurement. They reported 
CV values of 0.66%, 3.10% and 1.36% 
for lumbar spine, proximal tail and 
tibia, respectively in 7 female Sprague 
Dawley rats, using a similar DXA 
scanning (Ammann et al. 1992). The 
low value of %CV for whole body BMD 
in rats indicated that the measurements 
were reproducible. However, we did 
not perform segmental BMD analysis 
like previous studies.
 Quantum noise, changes in soft 
tissue composition, patient movement 
during the scans and scan analysis can 
influence the precision of DXA (Engelke 
et al. 1995). Correct positioning of 
patients or animals during a DXA scan 
is important in ensuring reproducible 
BMD results. Proper skills and training 
in positioning the subjects and 
intuition are required to obtain the 
best objective measurement (Carey 
& Delaney 2017). To our knowledge, 
this is the first study to report the short-
term coefficient of variance for small 
animal BMD using Hologic Discovery 
QDR Wi DXA machine.
CONCLUSION
Overall, the short-term precision 
of spinal and hip BMD of human 
and whole body BMD of rats using 
Hologic Discovery QDR Wi DXA was 
acceptable. The random error should 
be considered when interpreting the 
BMD results obtained in longitudinal 
studies.
Volunteer Reading 1 Reading 2 Reading 3 %CV (SD in g/cm2)
1 0.182 0.183 0.184 0.7 (0.001)
2 0.178 0.180 0.183 1.2 (0.002)
3 0.171 0.166 0.170 1.3(0.002)
4 0.162 0.167 0.166 1.5(0.003)
5 0.189 0.196 0.193 1.8(0.004)
6 0.181 0.182 0.184 0.2(<0.001)
7 0.188 0.193 0.188 1.5(0.003)
8 0.185 0.191 0.188 1.7(0.003)
9 0.181 0.180 0.185 1.5(0.003)
10 0.190 0.186 0.185 1.3(0.002)
11 0.186 0.184 0.186 0.4(0.001)
12 0.177 0.184 0.178 2.1(0.003)
13 0.167 0.161 0.168 2.3(0.004)
14 0.183 0.190 0.181 2.4(0.004)
15 0.179 0.175 0.176 1.4(0.002)
Range 0.2-2.4
 %CV 1.4
Abbreviation: CV: Coefficient of variance; SD: Standard deviation 
Table 3: In vivo precision for the whole body BMD of rats
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